Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox for Interstitial Cystitis in Women
NCT00194610Phase 4Completed
- Sponsor
- University of Washington
- Start
- May 2004
- Primary completion
- Jun 2009
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 4, randomised trial of botulinum toxin type A in interstitial cystitis (IC) (2 arms), sponsored by University of Washington. Primary endpoint: Chronic Prostatitis Symptom Index at 3 months. Started May 2004; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
interstitial cystitis (IC)
Beyond the preview
Go deeper on NCT00194610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00194610.